Research ArticleArticle
Investigating the Enteroenteric Recirculation of Apixaban, a Factor Xa Inhibitor: Administration of Activated Charcoal to Bile Duct-Cannulated Rats and Dogs Receiving an Intravenous Dose and Use of Drug Transporter Knockout Rats
Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
Drug Metabolism and Disposition April 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
Donglu Zhang
Bristol-Myers Squibb, Princeton, New Jersey
Charles E. Frost
Bristol-Myers Squibb, Princeton, New Jersey
Kan He
Bristol-Myers Squibb, Princeton, New Jersey
A. David Rodrigues
Bristol-Myers Squibb, Princeton, New Jersey
Xiaoli Wang
Bristol-Myers Squibb, Princeton, New Jersey
Lifei Wang
Bristol-Myers Squibb, Princeton, New Jersey
Theunis C. Goosen
Bristol-Myers Squibb, Princeton, New Jersey
W. Griffith Humphreys
Bristol-Myers Squibb, Princeton, New Jersey
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Enteroenteric and Renal Tubule Recirculation of Apixaban
Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
Drug Metabolism and Disposition April 1, 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
Research ArticleArticle
Enteroenteric and Renal Tubule Recirculation of Apixaban
Donglu Zhang, Charles E. Frost, Kan He, A. David Rodrigues, Xiaoli Wang, Lifei Wang, Theunis C. Goosen and W. Griffith Humphreys
Drug Metabolism and Disposition April 1, 2013, 41 (4) 906-915; DOI: https://doi.org/10.1124/dmd.112.050575
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement